Compare GIII & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIII | SDGR |
|---|---|---|
| Founded | 1956 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1989 | 2020 |
| Metric | GIII | SDGR |
|---|---|---|
| Price | $31.55 | $17.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $31.20 | $26.25 |
| AVG Volume (30 Days) | 521.2K | ★ 838.0K |
| Earning Date | 12-09-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.27 | N/A |
| Revenue | ★ $3,025,059,000.00 | $256,951,000.00 |
| Revenue This Year | N/A | $23.69 |
| Revenue Next Year | N/A | $20.46 |
| P/E Ratio | $9.80 | ★ N/A |
| Revenue Growth | N/A | ★ 32.90 |
| 52 Week Low | $20.33 | $15.99 |
| 52 Week High | $36.14 | $28.47 |
| Indicator | GIII | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 63.27 | 42.22 |
| Support Level | $30.18 | $17.53 |
| Resistance Level | $32.32 | $19.04 |
| Average True Range (ATR) | 1.23 | 0.76 |
| MACD | 0.14 | 0.07 |
| Stochastic Oscillator | 46.49 | 17.89 |
G-III Apparel Group Ltd is a textile company. It makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. G-III has a substantial portfolio for licensed and proprietary brands, anchored by five global power brands: DKNY, Donna Karan, Calvin Klein, Tommy Hilfiger, and Karl Lagerfeld. The company has two reportable operations: Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, as well as sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenues from Wholesale operations.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.